No gender differences in the progression of nervous system disease in HIV infectionROBERTSON, Kevin R; KAPOOR, Catherine; ROBERTSON, Wendy T et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 3, pp 817-822, issn 1525-4135, 6 p.Article

HIV-1 Expression Within Resting CD4⁺ T Cells After Multiple Doses of VorinostatARCHIN, Nancy M; BATESON, Rosalie; RICHMAN, Douglas D et al.The Journal of infectious diseases. 2014, Vol 210, Num 5, pp 728-735, issn 0022-1899, 8 p.Article

Highly active antiretroviral therapy improves neurocognitive functioningROBERTSON, Kevin R; ROBERTSON, Wendy T; FORD, Sutapa et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 562-566, issn 1525-4135, 5 p.Article

Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescentsPATEL, Kunjal; XUE MING; WILLIAMS, Paige L et al.AIDS (London). 2009, Vol 23, Num 14, pp 1893-1901, issn 0269-9370, 9 p.Article

Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological diseaseLINER, Kevin J; HALL, Colin D; ROBERTSON, Kevin R et al.Journal of neurovirology. 2007, Vol 13, Num 4, pp 291-304, issn 1355-0284, 14 p.Article

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression : A prospective study by AIDS clinical trials group 5170SKIEST, Daniel J; ZHAOHUI SU; MARGOLIS, David M et al.The Journal of infectious diseases. 2007, Vol 195, Num 10, pp 1426-1436, issn 0022-1899, 11 p.Article

Cerebrospinal fluid from human immunodeficiency virus-infected individuals facilitates neurotoxicity by suppressing intracellular calcium recoveryMEEKER, Rick B; BOLES, Jeramiah C; ROBERTSON, Kevin R et al.Journal of neurovirology. 2005, Vol 11, Num 2, pp 144-156, issn 1355-0284, 13 p.Article

Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed SuicideMOLLAN, Katie R; SMURZYNSKI, Marlene; TIERNEY, Camlin et al.Annals of internal medicine. 2014, Vol 161, Num 1, pp 1-10, issn 0003-4819, 10 p.Article

Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362COHN, Susan E; HONGYU JIANG; ALLEN MCCUTCHAN, J et al.AIDS Care (Print). 2011, Vol 23, Num 6, pp 775-785, issn 0954-0121, 11 p.Article

Improved Measures of Quality of Life, Lipid Profile, and Lipoatrophy After Treatment Interruption in HIV-Infected Patients With Immune Preservation : Results of ACTG 51 70SKIEST, Daniel J; KRAMBRINK, Amy; ZHAOHUI SU et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 4, pp 377-383, issn 1525-4135, 7 p.Article

The prevalence and incidence of neurocognitive impairment in the HAART eraROBERTSON, Kevin R; SMURZYNSKI, Marlene; PARSONS, Thomas D et al.AIDS (London). 2007, Vol 21, Num 14, pp 1915-1921, issn 0269-9370, 7 p.Article

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infectionPARSONS, Thomas D; TUCKER, Karen A; HALL, Colin D et al.AIDS (London). 2006, Vol 20, Num 12, pp 1591-1595, issn 0269-9370, 5 p.Article

Timed Gait Test : Normative Data for the Assessment of the AIDS Dementia ComplexROBERTSON, Kevin R; PARSONS, Thomas D; SIDTIS, John J et al.Neuropsychology, development, and cognition. Section A, journal of clinical and experimental neuropsychology. 2006, Vol 28, Num 7, pp 1053-1064, issn 1380-3395, 12 p.Article